IDFILL Trademark

Trademark Overview


On Friday, June 23, 2023, a trademark application was filed for IDFILL with the United States Patent and Trademark Office. The USPTO has given the IDFILL trademark a serial number of 98055970. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, June 26, 2024. This trademark is owned by C. R. Bard, Inc.. The IDFILL trademark is filed in the Medical Instrument Products category with the following description:

Medical devices and apparatus, namely, medical needles and syringes and parts and fittings therefor
idfill

General Information


Serial Number98055970
Word MarkIDFILL
Filing DateFriday, June 23, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, June 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 30, 2024

Trademark Statements


Pseudo MarkID FILL
Goods and ServicesMedical devices and apparatus, namely, medical needles and syringes and parts and fittings therefor

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, July 25, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameC. R. Bard, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFranklin Lakes, NJ 07417

Trademark Events


Event DateEvent Description
Tuesday, June 27, 2023NEW APPLICATION ENTERED
Tuesday, July 25, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 8, 2024ASSIGNED TO EXAMINER
Tuesday, March 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 26, 2024WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, March 27, 2024LETTER OF PROTEST EVIDENCE FORWARDED
Thursday, April 25, 2024LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN